Agnes Chan
Biochemistry
EUBIOS SRL ENGINEERING COMPANY
Canada
Biography
Agnes previously served as VP Preclinical Development at Dermira Inc. following its acquisition of Valocor Therapeutics in 2011. She co-founded Valocor in 2008, leading that company’s major R&D programs from inception as VP Project Direction/Operations. She previously served as Senior Director Project Management at QLT, managing all development activities including manufacturing, preclinical, clinical, regulatory affairs. She also served as Director of Clinical Research, leading Phase 1 and Phase 2 clinical development activities. Agnes received her PhD in Immunology from the University of British Columbia and completed her postdoctoral training at the Ontario Cancer Institute.
Research Interest
Biochemistry
